Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Improving Goal Directed Medical Therapy for Device Clinic Patients With Reduced Ejection Fraction at the University of Ottawa Heart Institute: a Quality Improvement Initiative (VIGILANT)

NCT05085249 is registered in ClinicalTrials.gov with Ottawa Heart Institute Research Corporation as lead sponsor.

NCT NCT05085249
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05085249 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Improving Goal Directed Medical Therapy for Device Clinic Patients With Reduced Ejection Fraction at the University of Ottawa Heart Institute: a Quality Improvement Initiative (VIGILANT)
Lead sponsor
Ottawa Heart Institute Research Corporation
Phase
Observational
Overall status
Completed
Start date
July 14, 2021
Completion date
December 31, 2021
Enrollment
2,479 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

heart failure